Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future

Omondi Michelle Atieno, Sylvia Opanga, Antony Martin, Amanj Kurdi, Brian Godman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background. Currently the majority of cancer deaths occur in low and middle-income countries where there are appreciable funding concerns. In Kenya, most patients currently pay out of pocket for treatment and those who are insured are generally not covered for the full costs of treatment. This places a considerable burden on households if family members develop cancer. However, the actual cost of cancer treatment in Kenya is unknown. Such an analysis is essential to better allocate resources as Kenya strives towards universal healthcare. Objectives. Evaluate the economic burden of treating cancer patients. Method. Descriptive cross-sectional cost of illness study in the leading teaching and referral hospital in Kenya, with data collected from the hospital files of sampled adult patients for treatment during 2016. Results: 412 patient files were reviewed, of which 63.4% (n=261) were female and 36.6% (n=151) male. Cost of cancer care is highly dependent on the modality. Most reviewed patients had surgery, chemotherapy and palliative care. The cost of cancer therapy varied with the type of cancer. Patients on chemotherapy alone cost an average of KES 138,207 (USD 1364.3); while those treated with surgery cost an average of KES 128,207 (1265.6), and those on radiotherapy KES 119,036 (1175.1). Some patients had a combination of all three, costing on average KES 333,462 (3291.8) per patient during the year. Conclusion. The cost of cancer treatment in Kenya depends on the type of cancer, the modality, cost of medicines and the type of inpatient admission. The greatest contributors are currently the cost of medicines and inpatient admissions. This pilot study can inform future initiatives among the government as well as private and public insurance companies to increase available resources, and better allocate available resources, to more effectively treat patients with cancer in Kenya. We will be monitoring developments and conducting further research
LanguageEnglish
Pages878-887
Number of pages10
JournalJournal of Medical Economics
Volume21
Issue number9
Early online date2 Jun 2018
DOIs
Publication statusPublished - 21 Jun 2018

Fingerprint

Kenya
Costs and Cost Analysis
Neoplasms
Health Care Costs
Inpatients
Drug Therapy
Cost of Illness
Insurance
Palliative Care
Teaching Hospitals
Radiotherapy
Therapeutics
Referral and Consultation
Economics
Delivery of Health Care

Keywords

  • cancer treatment
  • medical costs
  • Kenya

Cite this

@article{500c112a24fb4b09b73bbfe1862d08d2,
title = "Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future",
abstract = "Background. Currently the majority of cancer deaths occur in low and middle-income countries where there are appreciable funding concerns. In Kenya, most patients currently pay out of pocket for treatment and those who are insured are generally not covered for the full costs of treatment. This places a considerable burden on households if family members develop cancer. However, the actual cost of cancer treatment in Kenya is unknown. Such an analysis is essential to better allocate resources as Kenya strives towards universal healthcare. Objectives. Evaluate the economic burden of treating cancer patients. Method. Descriptive cross-sectional cost of illness study in the leading teaching and referral hospital in Kenya, with data collected from the hospital files of sampled adult patients for treatment during 2016. Results: 412 patient files were reviewed, of which 63.4{\%} (n=261) were female and 36.6{\%} (n=151) male. Cost of cancer care is highly dependent on the modality. Most reviewed patients had surgery, chemotherapy and palliative care. The cost of cancer therapy varied with the type of cancer. Patients on chemotherapy alone cost an average of KES 138,207 (USD 1364.3); while those treated with surgery cost an average of KES 128,207 (1265.6), and those on radiotherapy KES 119,036 (1175.1). Some patients had a combination of all three, costing on average KES 333,462 (3291.8) per patient during the year. Conclusion. The cost of cancer treatment in Kenya depends on the type of cancer, the modality, cost of medicines and the type of inpatient admission. The greatest contributors are currently the cost of medicines and inpatient admissions. This pilot study can inform future initiatives among the government as well as private and public insurance companies to increase available resources, and better allocate available resources, to more effectively treat patients with cancer in Kenya. We will be monitoring developments and conducting further research",
keywords = "cancer treatment, medical costs, Kenya",
author = "Atieno, {Omondi Michelle} and Sylvia Opanga and Antony Martin and Amanj Kurdi and Brian Godman",
year = "2018",
month = "6",
day = "21",
doi = "10.1080/13696998.2018.1484372",
language = "English",
volume = "21",
pages = "878--887",
journal = "Journal of Medical Economics",
issn = "1369-6998",
number = "9",

}

Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future. / Atieno, Omondi Michelle ; Opanga, Sylvia; Martin, Antony; Kurdi, Amanj; Godman, Brian.

In: Journal of Medical Economics, Vol. 21, No. 9, 21.06.2018, p. 878-887.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future

AU - Atieno, Omondi Michelle

AU - Opanga, Sylvia

AU - Martin, Antony

AU - Kurdi, Amanj

AU - Godman, Brian

PY - 2018/6/21

Y1 - 2018/6/21

N2 - Background. Currently the majority of cancer deaths occur in low and middle-income countries where there are appreciable funding concerns. In Kenya, most patients currently pay out of pocket for treatment and those who are insured are generally not covered for the full costs of treatment. This places a considerable burden on households if family members develop cancer. However, the actual cost of cancer treatment in Kenya is unknown. Such an analysis is essential to better allocate resources as Kenya strives towards universal healthcare. Objectives. Evaluate the economic burden of treating cancer patients. Method. Descriptive cross-sectional cost of illness study in the leading teaching and referral hospital in Kenya, with data collected from the hospital files of sampled adult patients for treatment during 2016. Results: 412 patient files were reviewed, of which 63.4% (n=261) were female and 36.6% (n=151) male. Cost of cancer care is highly dependent on the modality. Most reviewed patients had surgery, chemotherapy and palliative care. The cost of cancer therapy varied with the type of cancer. Patients on chemotherapy alone cost an average of KES 138,207 (USD 1364.3); while those treated with surgery cost an average of KES 128,207 (1265.6), and those on radiotherapy KES 119,036 (1175.1). Some patients had a combination of all three, costing on average KES 333,462 (3291.8) per patient during the year. Conclusion. The cost of cancer treatment in Kenya depends on the type of cancer, the modality, cost of medicines and the type of inpatient admission. The greatest contributors are currently the cost of medicines and inpatient admissions. This pilot study can inform future initiatives among the government as well as private and public insurance companies to increase available resources, and better allocate available resources, to more effectively treat patients with cancer in Kenya. We will be monitoring developments and conducting further research

AB - Background. Currently the majority of cancer deaths occur in low and middle-income countries where there are appreciable funding concerns. In Kenya, most patients currently pay out of pocket for treatment and those who are insured are generally not covered for the full costs of treatment. This places a considerable burden on households if family members develop cancer. However, the actual cost of cancer treatment in Kenya is unknown. Such an analysis is essential to better allocate resources as Kenya strives towards universal healthcare. Objectives. Evaluate the economic burden of treating cancer patients. Method. Descriptive cross-sectional cost of illness study in the leading teaching and referral hospital in Kenya, with data collected from the hospital files of sampled adult patients for treatment during 2016. Results: 412 patient files were reviewed, of which 63.4% (n=261) were female and 36.6% (n=151) male. Cost of cancer care is highly dependent on the modality. Most reviewed patients had surgery, chemotherapy and palliative care. The cost of cancer therapy varied with the type of cancer. Patients on chemotherapy alone cost an average of KES 138,207 (USD 1364.3); while those treated with surgery cost an average of KES 128,207 (1265.6), and those on radiotherapy KES 119,036 (1175.1). Some patients had a combination of all three, costing on average KES 333,462 (3291.8) per patient during the year. Conclusion. The cost of cancer treatment in Kenya depends on the type of cancer, the modality, cost of medicines and the type of inpatient admission. The greatest contributors are currently the cost of medicines and inpatient admissions. This pilot study can inform future initiatives among the government as well as private and public insurance companies to increase available resources, and better allocate available resources, to more effectively treat patients with cancer in Kenya. We will be monitoring developments and conducting further research

KW - cancer treatment

KW - medical costs

KW - Kenya

UR - https://www.tandfonline.com/loi/ijme20

U2 - 10.1080/13696998.2018.1484372

DO - 10.1080/13696998.2018.1484372

M3 - Article

VL - 21

SP - 878

EP - 887

JO - Journal of Medical Economics

T2 - Journal of Medical Economics

JF - Journal of Medical Economics

SN - 1369-6998

IS - 9

ER -